P659-1925 Screening compound: 1-(4-methoxyphenyl)-4-{[5-methyl-7-(4-methylpiperidin-1-yl)-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl]methyl}piperazine

P659-1925 Screening compound: 1-(4-methoxyphenyl)-4-{[5-methyl-7-(4-methylpiperidin-1-yl)-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl]methyl}piperazine
P659-1925 Screening compound: 1-(4-methoxyphenyl)-4-{[5-methyl-7-(4-methylpiperidin-1-yl)-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl]methyl}piperazine alternative view

Chemical Structure Depiction of ChemDiv screening compound P659-1925
1-(4-methoxyphenyl)-4-{[5-methyl-7-(4-methylpiperidin-1-yl)-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl]methyl}piperazine

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

P659-1925

Molecular Formula

C24H33N7O (C24 H33 N7 O)

Compound Name

1-(4-methoxyphenyl)-4-{[5-methyl-7-(4-methylpiperidin-1-yl)-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl]methyl}piperazine

IUPAC name

1-(4-methoxyphenyl)-4-{[5-methyl-7-(4-methylpiperidin-1-yl)-[124]triazolo[15-a]pyrimidin-2-yl]methyl}piperazine

SMILES

CC(CC1)CCN1c1cc(C)nc2nc(CN(CC3)CCN3c(cc3)ccc3OC)nn12

InChI

InChI=1S/C24H33N7O/c1-18-8-10-30(11-9-18)23-16-19(2)25-24-26-22(27-31(23)24)17-28-12-14-29(15-13-28)20-4-6-21(32-3)7-5-20/h4-7,16,18H,8-15,17H2,1-3H3

InChI Key

PUXZWQBOYVDKHR-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27609857

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

435.57

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

3.517

Distribution Coefficient, logD

3.487

Water Solubility, LogSw

-3.48

Polar Surface Area

48.916

Acid Dissociation Constant (pKa)

24.11

Base Dissociation Constant (pKb)

6.26

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

54.20

P659-1925 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

SmartTM Library (51161 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
Targets:
  • Proteases

References: we are preparing a list of scientific research reports with P659-1925 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound P659-1925?
Check Price and Availability of P659-1925, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of P659-1925 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for P659-1925
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for P659-1925
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of P659-1925 available by request